Table 1

Patient, procedural, and outcome metrics of stroke patients treated with mechanical thrombectomy at the 28 international sites and divided by COVID-19 status

All patients (n=458)COVID-19 positive patents (n=13)Non-COVID-19 patients (n=445)P-value*
Age, median (IQR)71 (60–80)58 (50–71)72 (60–80) 0.04
Females, n (%)210 (45.9%)5 (38.5%)205 (46.1%)0.779
White, n (%)310 (67.7%)6 (46.2%)304 (68.3%)0.129
LKN to hospital door, median (IQR)260 (119–506)202 (92–606)260 (119–506)0.557
Admission NIHSS, median (IQR)16 (10–21)19 (16–24)15 (10–20) 0.047
IV-tPA, n (%)184 (40.2%)4 (30.8%)180 (40.4%)0.576
ASPECTS, median (IQR)†8 (7–10)9 (8–10)8 (7–10)0.249
Posterior circulation, n (%)46 (10%)046 (10.3%)0.38
Intubation, n (%)241 (52.6%)5 (38.5%)236 (53%)0.4
Door to groin, median (IQR)81 (50–127)56 (37–150)82 (50–127)0.315
LKN to groin, median (IQR)351 (200–654)259 (181–343)355 (200–659)0.118
Number of passes during thrombectomy, median (IQR)2 (1–3)2 (1–4)2 (1–3)0.189
Successful recanalization (mTICI ≥2 b), n (%)381 (83.2%)13 (100%)368 (82.7%)0.138
Procedure duration, median (IQR)40 (24–66)45 (29–76)40 (24–66)0.455
Door to reperfusion, median (IQR)120 (75–178)86 (35–154)122 (76–178)0.064
Length of stay, median (IQR)5 (3–10)8 (4–15)5 (3–10)0.231
sICH, n (%)28 (6.1%)2 (15.4%)26 (5.8%)0.185
In-hospital mortality, n (%)‡80 (24.4)4 (33.3%)76 (24.1%)0.496
DC mRS, median (IQR)‡4 (2–5)4 (3–6)4 (2–5)0.443
Functional independence on discharge (mRS 0–2), n (%)‡96 (29.2%)2 (16.7%)94 (29.7%)0.52
  • *Calculated using Fisher's exact test for categorical variables and Wilcoxon test for the continuous variables.

  • †Only for patients with anterior circulation occlusion.

  • ‡Missing for 130 patients.

  • ASPECTS, Alberta Stroke Program Early CT score; COVID-19, coronavirus disease of 2019; IV-tPA, intravenous tissue plasminogen activator; LKN, last known normal; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale; sICH, symptomatic intracerebral hematoma.